Top Markets
#1 Islamic Coin Islamic Coin +152.25%
#2 Bitway Bitway +51.75%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.86%
#4 Starpower Starpower +35.57%
#5 Pons Pons +21.26%
#6 aelf aelf +20.04%
#7 Pleasing Gold Pleasing Gold +17.74%
#8 Venom Venom +14.91%
#9 Decred Decred +14.50%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Ji Yao Holding Group Co., Ltd. Ji Yao Holding Group Co., Ltd.

Ji Yao Holding Group Co., Ltd.

300108
Rank in Stocks #29843
Ji Yao Holding Group Co., Ltd. functions as a pharmaceutical enterprise,... Ji Yao Holding Group Co., Ltd. functions as a pharmaceutical enterprise, primarily involved in the research, development, production, and wholesale distribution of various medical products. Its extensive product line features both traditional Chinese and modern Western medicines, designed to treat a wide array of health issues. These encompass pediatric conditions, respiratory illnesses, women's health, cardiovascular disorders, viral infections, urinary tract problems, inflammatory diseases, gastrointestinal complaints, general wellness tonics, and rheumatic ailments. The company was founded in 2000 and is headquartered in Meihekou, China.
Share Price
$0.02912824
Last synced: 2025-05-19
Market Cap
$19.41M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade Ji Yao Holding Group Co., Ltd. (300108)

Category

Healthcare
Revenue for Ji Yao Holding Group Co., Ltd. (300108)
Revenue in Aug 2026 TTM: 0
According to Ji Yao Holding Group Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ji Yao Holding Group Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT